AAV 3.0

Welcome to the Brand page for “AAV 3.0”, which is offered here for Chemical preparations for gene therapy for treating genetic disorders; viral medicines; gene therapy medicines; nucleic acid delivery medicines; viral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for use in nucleic acid-based therapy, gene therapy and cell therapy in the treatment of human diseases;aav three point 0;gene therapy assays; gene therapy reagents; gene therapy preparations; nucleic acid delivery assays; nucleic acid delivery reagents; nucleic acid delivery preparations; viral vectors; gene therapy vectors; nucleic acid delivery vectors; cells and tissues transformed by viral vectors, gene therapy vectors, and nucleic acid delivery vectors;gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of human diseases;aav;testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific and medical research and development, laboratory research in the field of gene therapy vectors for medical and research purposes; genetic engineering biotechnology services, research and development of new technology in the field of biotechnology; product development services related to gene therapy products and instruments; consultation services in the fields of medical and scientific research in the field of gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “AAV 3.0” is believed to be currently owned by “THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA”.